Exploring significant advancements in autoimmune hepatitis and liver disease treatments.
Emerging treatments, advocacy milestones, and diagnostic challenges.
Clinical trials expand potential, genetic research reveals insights, and patient stories highlight challenges.
The interplay between hepatocytes and T cells in autoimmune hepatitis, the potential of T cell biomarkers to predict relapse, and a case of chronic Epstein-Barr virus mimicking autoimmune hepatitis.
